Cipher Pharmaceuticals Inc. ( CPHRF) - Key Metrics
CPHRF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.46 | $0.15 | $0.12 | $0.12 |
| 2026Q1 | $0.49 | $0.24 | $0.18 | $0.18 |
| 2025Q4 | $0.49 | $0.53 | $0.35 | $0.35 |
| 2025Q3 | $0.51 | $0.22 | $0.42 | $0.42 |
| 2025Q2 | $0.52 | $0.23 | $0.23 | $0.23 |
CPHRF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 19.30 |
| 2026Q1 | 0% | 13.60 |
| 2025Q4 | 0% | 5.18 |
| 2025Q3 | 0% | 13.24 |
| 2025Q2 | 0% | 10.00 |
CPHRF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.01% | 0% |
| 2026Q1 | 1.35% | 0% |
| 2025Q4 | 3.19% | 0% |
| 2025Q3 | 3.78% | 0% |
| 2025Q2 | 2.53% | 0% |
CPHRF
Price: $9.63
52 week price:
Earnings Per Share: 0.67 USD
P/E Ratio: 16.42
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 244.5 million